VERTEX PHARMACEUTICALS INC / MA Insider Trading for October 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for October 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 251 | 0 | 9,087 | |
| Oct 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 14,875 | |
| Oct 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 177.20 | 2,125 | 376,550 | 39,609 | 41.7 K to 39.6 K (-5.09 %) |
| Oct 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 41,734 | 39.6 K to 41.7 K (+5.36 %) |
| Oct 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 186.95 | 2,305 | 430,920 | 1,909 | 4.2 K to 1.9 K (-54.70 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 122.45 | 4,250 | 520,413 | 21,250 | |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 191.58 | 4,250 | 814,215 | 39,609 | 43.9 K to 39.6 K (-9.69 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 122.45 | 4,250 | 520,413 | 43,859 | 39.6 K to 43.9 K (+10.73 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 126.68 | 4,700 | 595,396 | 14,547 | |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 125.71 | 2,118 | 266,254 | 3,177 | |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 192.13 | 4,700 | 903,011 | 4,879 | 9.6 K to 4.9 K (-49.07 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Buy | M | 126.68 | 4,700 | 595,396 | 9,579 | 4.9 K to 9.6 K (+96.33 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 192.13 | 2,118 | 406,931 | 4,879 | 7 K to 4.9 K (-30.27 %) |
| Oct 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Buy | M | 125.71 | 2,118 | 266,254 | 6,997 | 4.9 K to 7 K (+43.41 %) |
| Oct 02 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 2,445 | 380,369 | 17,121 | |
| Oct 02 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 194.62 | 2,445 | 475,846 | 39,113 | 41.6 K to 39.1 K (-5.88 %) |
| Oct 02 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 2,445 | 380,369 | 41,558 | 39.1 K to 41.6 K (+6.25 %) |
| Oct 02 2018 | VRTX | VERTEX PHARMACEUTI ... | Graney Thomas | Chief Financial Off ... | Sell | S | 193.24 | 1,076 | 207,926 | 12,430 | 13.5 K to 12.4 K (-7.97 %) |